PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Madopar, Prolopa, Prolopa 100/25, Prolopa 200/50

What is Levodopa-Benserazide? Levodopa is the precursor molecule to dopamine, an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide is an additive which allows the levodopa to continue circulating in the body for longer.


Reasons Taken

22 patients in the community are taking or have taken Levodopa-Benserazide.

Reason # Patients Percentage of patients
Treat Parkinson's 15 68%
Other 3 13%
Stiffness/spasticity 1 4%
Slowness 1 4%
spastisity 1 4%

Dosages

Based on the patients currently taking Levodopa-Benserazide.

Top 10 (Show all)

All (Show Top 10)

  2 mg Daily 25 mg Daily 50 mg Daily 62.5 mg Daily 100 mg Daily 125 mg Daily 375 mg Daily 400 mg Daily 425 mg Daily 500 mg Daily 750 mg Daily 1087.5 mg Daily 1500 mg Daily 1550 mg Daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Levodopa-Benserazide or how long patients were taking Levodopa-Benserazide before stopping.

Currently taking Levodopa-Benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
1
1
5

Stopped taking Levodopa-Benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
1
0
Why Patients Stopped Taking Levodopa-Benserazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 2 67% Other: 67%
Not indicated 1 33% Not indicated: 33%

Patient Reported Evaluations

Results from 2 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 50% 1
Moderate 50% 1

Treat Parkinson's

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 2

Top reported side-effects include:

Summary results are based on 2 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 2)

  • asb
    Sex: M
    Mouth/throat: none
    Arms: mild
    Chest: none
    Legs: mild
    See profile
  • asb
  • by asb
    Sep 14, 2008
  • EfficacyModerate
  • Side-effectsNone
  • Treat Parkinson's
Advice/Tips
results have varied a lot; the dose has been upped several times over 3 years

See all evaluation results for Levodopa-Benserazide



Back to top